ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2348

Does Arthritis in Other Joints and Spine Influence the 1-Year Outcome of Total Hip Replacement? a Prospective European Multicenter Cohort Study  Measuring the Influence of Musculoskeletal Morbidity

Joerg Huber1, Paul Dieppe2, Karsten Dreinhoefer3, Klaus-Peter Günther4, Georg Ruflin5 and Andrew Judge6, 1Orthopedics, Triemli Spital, Zurich, Switzerland, 2Exeter Medical School, University of Exeter, Exeter, United Kingdom, 3Centre of Musculosceletal Surgery, Charité, Charite, Berlin, Berlin, Germany, 4University Center of Orthopedics and Traumatology, Technische Universität, Dresden, Germany, 5Orthopedics, Kantonsspital Aarau, Aarau, Switzerland, 6Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Comorbidity, Hip, OA, outcomes and total joint replacement

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Osteoarthritis – Clinical Aspects - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Whilst arthritis in other affected joints and back pain is known to lead to worse outcomes following total hip replacement surgery, these risk factors have not previously been operationalized as a musculoskeletal morbidity profile. The aim of this study was to measure the influence of other joints and spine (in four musculoskeletal morbidity grades) on the 1-year outcome of primary hip replacement.

Methods: The European Collaborative Database of Cost and Practice Patterns of Total Hip Replacement study (EUROHIP) consists of 1,327 patients receiving primary THR for osteoarthritis (OA) across 20 European orthopedic centers. The primary outcome was whether or not a patient responded to THR at 12-months as measured by the relative effect per patient (REPP score), calculated for each patient using the total WOMAC score. The primary predictor of interest was the grade of musculoskeletal morbidity (MSM). The cohort was grouped into four combinations of arthritis based on the index joint, other large joints and spine respectively: MSM grade 1 (single-joint), 2 (multi-joints), 3 (single-joint and spine), 4 (multi-joints and spine) (Table 1). Confounders adjusted for were: age, sex, body mass index, living alone, years of hip pain, ASA grade, anxiety/depression, pre-operative WOMAC subscales.

Results: 845 patients were included for this analysis with complete 12-month follow-up WOMAC scores. The mean age was 65.7 years and 55.2% were female. Increasing MSM grade was associated with worse outcomes of surgery, where the responder rates for THR were: 254 (92.4%) MSM grade 1, 272 (87.2%) MSM grade 2, 46 (80.7%) MSM grade 3, 142 (74.4%) MSM grade 4. This was confirmed in adjusted logistic regression models: MSM grade 4 vs. 1 odds ratio (OR) 0.26 95% confidence interval (CI) (0.14, 0.46); MSM grade 3 vs. 1 OR 0.32 95%CI (0.14, 0.73); MSM grade 2 vs. 1 OR 0.56 95%CI (0.32, 1.00) (Fig.1).

Conclusion: Other joints and spine measured as musculoskeletal morbidity have a strong influence on the 1-year outcome after THR. The effect size was large in comparison to other risk factors. Even so, the majority of patients in MSM grade 4 can still profit from surgery (>75% responder rate).


Disclosure: J. Huber, None; P. Dieppe, None; K. Dreinhoefer, None; K. P. Günther, None; G. Ruflin, None; A. Judge, None.

To cite this abstract in AMA style:

Huber J, Dieppe P, Dreinhoefer K, Günther KP, Ruflin G, Judge A. Does Arthritis in Other Joints and Spine Influence the 1-Year Outcome of Total Hip Replacement? a Prospective European Multicenter Cohort Study  Measuring the Influence of Musculoskeletal Morbidity [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/does-arthritis-in-other-joints-and-spine-influence-the-1-year-outcome-of-total-hip-replacement-a-prospective-european-multicenter-cohort-study-measuring-the-influence-of-musculoskeletal-mo/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/does-arthritis-in-other-joints-and-spine-influence-the-1-year-outcome-of-total-hip-replacement-a-prospective-european-multicenter-cohort-study-measuring-the-influence-of-musculoskeletal-mo/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology